drugset / Trial / NCT00486083

Comparison Atomoxetine Hydrochloride and Comparator in Pediatric Outpatients With ADHD

NCT00486083

Phase 3 Completed 330 enrolled Eli Lilly and Company
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of the study is to compare atomoxetine hydrochloride and methylphenidate hydrochloride in pediatric patients with ADHD.

Timeline

Start
2003-12
Primary completion
Completion
2004-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Atomoxetine Other / unclassified
Subject Methylphenidate Small molecule